Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
54.55
-0.08 (-0.15%)
At close: Dec 5, 2025, 4:00 PM EST
54.53
-0.02 (-0.04%)
After-hours: Dec 5, 2025, 5:40 PM EST

Akero Therapeutics Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Akero Therapeutics stock ranges from a low of $54 to a high of $109. The average analyst price target of $73.56 forecasts a 34.85% increase in the stock price over the next year.

Price Target: $73.56 (+34.85%)
Analyst Consensus: Buy
Target Low Average Median High
Price $54 $73.56 $75 $109
Change -1.01% +34.85% +37.49% +99.82%
* Price targets were last updated on Oct 10, 2025.

Analyst Ratings

The average analyst rating for Akero Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 567555
Buy 311111
Hold 000444
Sell 000000
Strong Sell 000000
Total 878101010

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wolfe Research
Wolfe Research
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Oct 10, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$72$54
Hold Downgrades $72$54 -1.01% Oct 10, 2025
Jefferies
Jefferies
Hold
Downgrades
$75$56
Hold Downgrades $75$56 +2.66% Oct 9, 2025
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
$73$54
Hold Downgrades $73$54 -1.01% Oct 9, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$72
Strong Buy Initiates $72 +31.99% Sep 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.79
from -3.75
EPS Next Year
-4.40
from -3.79
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-2.52-2.89-2.87-2.89-3.75-3.79-4.40
EPS Growth
-------
Forward PE
-------
No. Analysts
-----109
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -3.77 -4.18
Avg -3.79 -4.40
Low -3.86 -4.90

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.